Finding the best follow-up care after prostate cancer treatment
Part of Cancer, Kidney & urinary clinical trials.
This study compares different follow-up approaches after curative treatment for early-stage prostate cancer. It aims to find the best way to monitor patients after treatment, which may help improve quality of life and reduce unnecessary tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with prostate cancer that had not spread outside the prostate (non-metastatic, localised) between 2018 and 2023.
- You are 18 years or older at diagnosis.
- You completed primary curative treatment (surgery, radiation, or focal therapy) between 2019 and 2023.
- You were alive with no evidence of cancer spread or recurrence 6 months after completing treatment.
- You have not had treatment for metastatic (spread) cancer or palliative care for prostate cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with newly diagnosed prostate cancer to understand care decisions and outcomes over the long term. It uses routine medical information and asks you to complete questionnaires, which may help improve future treatment and support.
This Phase 3 study compares an immediate curative treatment plan versus a more conservative approach in men age 75 and older with newly diagnosed, high-risk prostate cancer. The goal is to see which strategy controls the cancer while better protecting quality of life.
This trial looks at long-term results after radiation therapy for prostate cancer. By studying PSA test results and imaging scans from men who were treated at least 10 years ago, researchers hope to learn more about side effects and how well the treatment worked over time.
This study collects information from men with prostate cancer to better understand how different treatments work in real life. It follows patients when they start a new treatment and can help improve future care.
This study tracks men with intermediate-risk prostate cancer who had a newer, targeted treatment that only treats the cancer area, not the whole prostate. It aims to see how well these treatments work in real life and may help guide future care.
This study follows men with low-risk prostate cancer who choose active surveillance (watching closely instead of immediate treatment). It aims to better track which monitoring results stay reassuring over time, and when treatment might be needed.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.